Advanced Medical Solutions Group (CHIX:AMSL) Current Ratio: 2.79 (As of Dec. 2025) — 53% Below Median


CHIX:AMSL Advanced Medical Solutions Group PLC CHIX:AMSL
93 GF Score
Price £2.78
GF Value £3.71
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group Current Ratio?

Advanced Medical Solutions Group CHIX:AMSL +14.17% 93 Current Ratio is 2.79 as of Dec. 2025, which is 53% below its 10-year median of 5.97. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.71 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 55.62% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Advanced Medical Solutions Group's current ratio for the quarter that ended in Dec. 2025 was 2.79.

Advanced Medical Solutions Group has a current ratio of 2.79. It generally indicates good short-term financial strength.

The historical rank and industry rank for Advanced Medical Solutions Group's Current Ratio or its related term are showing as below:

CHIX:AMSl' s Current Ratio Range Over the Past 10 Years
Min: 2.79   Med: 5.97   Max: 6.89
Current: 2.79

During the past 13 years, Advanced Medical Solutions Group's highest Current Ratio was 6.89. The lowest was 2.79. And the median was 5.97.

CHIX:AMSl's Current Ratio is ranked better than
55.62% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 2.485 vs CHIX:AMSl: 2.79

Advanced Medical Solutions Group  (CHIX:AMSl) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Advanced Medical Solutions Group Current Ratio Related Terms


Advanced Medical Solutions Group Current Ratio Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group Current Ratio Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.76 5.82 5.67 2.85 2.79

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 8.39 2.85 2.88 2.79

CHIX:AMSL vs ISRG, BDX, MDLN: Current Ratio Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group Current Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Current Ratio distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Current Ratio falls into.


CHIX:AMSL
93GF Score
Advanced Medical Solutions Group PLC CHIX:AMSL
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Advanced Medical Solutions Group's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=139.365/49.946
=2.79

Advanced Medical Solutions Group's Current Ratio for the quarter that ended in Dec. 2025 is calculated as

Current Ratio (Q: Dec. 2025 )=Total Current Assets (Q: Dec. 2025 )/Total Current Liabilities (Q: Dec. 2025 )
=139.365/49.946
=2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 2.79 mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a Current Ratio of 2.79 as of Dec. 2025. This is 53% below median its historical median of 5.97. Over the past decade, Advanced Medical Solutions Group's Current Ratio has ranged from 2.79 to 6.89. According to the industry distribution chart, Advanced Medical Solutions Group ranks #379 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 44.4%.
Is Advanced Medical Solutions Group's Current Ratio too high?
Advanced Medical Solutions Group's current Current Ratio of 2.79 is 53% below median its 10-year median of 5.97. Over the past 10 years, this metric has ranged from a low of 2.79 to a high of 6.89. The Medical Devices & Instruments industry median Current Ratio is 2.49. Advanced Medical Solutions Group's value of 2.79 is 12.3% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #379 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #379 out of 854 companies for Current Ratio. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median Current Ratio is 2.49. Advanced Medical Solutions Group's value of 2.79 is 12.3% above this benchmark. Historically, Advanced Medical Solutions Group's own Current Ratio has ranged from 2.79 to 6.89 over the past decade. While the company's 10-year median is 5.97 vs. the industry median of 2.49, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Current Ratio of 2.79 is 12.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Current Ratio is 2.79, which is 53% below median its own 10-year median of 5.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.78 — trading 25.1% below its estimated fair value. The current Current Ratio is 2.79, which is 53% below median its 10-year median of 5.97 and 12.3% above the Medical Devices & Instruments industry median of 2.49. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Current Ratio is 2.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.78 is trading 25.1% below its estimated GF Value™ of £3.71. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for CHIX:AMSL:

  • Current Ratio: 2.79 (53% below median its 10-year median of 5.97)
  • GF Value™: £3.71 vs. price of £2.78 (25.1% below fair value)
  • GF Score™: 93/100 with 6 warning signs
  • Industry Position: 12.3% above the Medical Devices & Instruments median (#379 of 854)

No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMS:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score

Get the complete analysis for CHIX:AMSL

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.78
Price
£3.71
GF Value